Problem being addressed[edit | edit source]
Pneumonia is a major cause of death for infants and children in resource-limited settings. Since oxygen therapy is expensive and requires medical professionals, antibiotics are the often the only treatment.
Detailed description of the solution[edit | edit source]
Inspire converts room air into pressurized gas to expand patients' lung instead of using oxygen tanks like traditional bubble CPAP methods. Doctors can direct oxygen into the Inspire device if oxygen supplements are necessary. Since pure oxygen in excess doses can result in blindness and asthma, this device is also safer for less-trained professionals to use.
Designed by[edit | edit source]
- Designed by: A team at Stanford University
- Manufacturer location: Stanford University
When and where it was tested/implemented[edit | edit source]
Bangladesh
Funding Source[edit | edit source]
National Institutes of Health grant
References[edit | edit source]
Other internally generated reports[edit | edit source]
Pavkov, Pamela. (2011). INSPIRE: Evaluating a Transition to Product Development. Retrieved November 29, 2013 from here.
Externally generated reports[edit | edit source]
Pavkov, Pamela. (July 5, 2011). OpenIDEO. Inspire: a low-cost breathing assistant for infants in rural settings. Retrieved November 29, 2013 from here.